FDA Clearance Tracker · P020014-S018
CONCEPTUS ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL
Last checked: Nov 20, 2026Latest source record: Mar 16, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Mar 16, 2009
Approved
Time to decision
293 days
Received May 27, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P020014-S018
- Device name
- CONCEPTUS ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL
- Applicant
- Bayer Pharma AG
- Applicant location
- Berlin
- Received
- May 27, 2008
- Decided
- Mar 16, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P020014
Device type
- Device class
- Class III
- Regulation
- 21 CFR 884.5380
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Bayer Pharma AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.